Adamis pharmaceuticals announces 2020 financial results and business update

Phase 2/3 clinical trial for tempol for the prevention of hospitalizations in patients with covid-19 expected to initiate in the second quarter of 2021
ADMP Ratings Summary
ADMP Quant Ranking